摘要
背景:阿尔茨海默病(AD)和年龄相关性黄斑变性(AMD)存在相似性,特别是在氧化应激方面,包括4-羟基-2-壬烯醛(HNE)的产生。 AMD已被视为AD。 Muller细胞(MC)作为视网膜的主要胶质细胞并维持水/钾,谷氨酸盐稳态和氧化还原状态。任何MC功能障碍都会导致视网膜神经变性。 目标:我们调查了HNE在人类MC中的作用。 结果:HNE诱导与线粒体功能障碍和细胞凋亡相关的活性氧的增加。 HNE诱导内质网(ER)应激(GRP78 / Bip上调,以及促凋亡因子CHOP)。 HNE还影响控制钾稳态(KCNJ10),谷氨酸解毒(GS)和视觉周期(RLBP1)的基因的表达。 MC对HNE的适应性反应包括淀粉样β蛋白前体(AβPP)的上调。为了确定AβPP的作用,我们在MC中过表达AβPP。 AβPP的过度表达引起强抗氧化和抗ER应激(PERK下调和GADD34上调)响应,伴随着未折叠蛋白响应的促存活分支的激活。它也与MC控制的视网膜内稳态(KCNJ10,GS和RLBP1)中涉及的主要基因的上调和对抗HNE诱导的细胞凋亡的保护有关。因此,AβPP是ER和氧化应激反应分子,并且能够刺激HNE损伤的MC功能中涉及的主要基因的转录。 结论:根据两种病理学的共同特点,我们的研究表明,针对氧化应激和内质网应激可能是针对AMD和AD中神经胶质损伤的潜在治疗策略。
关键词: AβPP,氧化应激,神经胶质细胞,阿尔茨海默病,年龄相关性黄斑变性,视网膜。
Current Alzheimer Research
Title:AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival
Volume: 15 Issue: 7
关键词: AβPP,氧化应激,神经胶质细胞,阿尔茨海默病,年龄相关性黄斑变性,视网膜。
摘要: Background: Alzheimer's disease (AD) and age-related macular degeneration (AMD) present similarities, particularly with respect to oxidative stress, including production of 4-Hydroxy-2- nonenal (HNE). AMD has been named the AD in the eye. The Müller cells (MC) function as a principal glia of the retina and maintain water/potassium, glutamate homeostasis and redox status. Any MC dysfunction results in retinal neurodegeneration.
Objectives: We investigated the effects of HNE in human MC.
Results: HNE induced an increase of the reactive oxygen species associated with mitochondrial dysfunction and apoptosis. HNE induced endoplasmic reticulum (ER) stress (upregulation of GRP78/Bip, and the proapoptotic factor, CHOP). HNE also impaired expression of genes controlling potassium homeostasis (KCNJ10), glutamate detoxification (GS), and the visual cycle (RLBP1). MC adaptive response to HNE included upregulation of amyloid-β protein precursor (AβPP). To determine the role of AβPP, we overexpressed AβPP in MC. Overexpression of AβPP induced strong antioxidant and anti-ER stress (PERK downregulation and GADD34 upregulation) responses accompanied by activation of the prosurvival branch of the unfolded protein response. It was also associated with upregulation of major genes involved in MC-controlled retinal homeostasis (KCNJ10, GS, and RLBP1) and protection against HNE-induced apoptosis. Therefore, AβPP is an ER and oxidative stress responsive molecule, and is able to stimulate the transcription of major genes involved in MC functions impaired by HNE.
Conclusion: Our study suggests that targeting oxidative and ER stress might be a potential therapeutic strategy against glia impairment in AMD and AD, in light of the common features between the two pathologies.
Export Options
About this article
Cite this article as:
AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival, Current Alzheimer Research 2018; 15 (7) . https://dx.doi.org/10.2174/1567205015666180119101832
DOI https://dx.doi.org/10.2174/1567205015666180119101832 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Investigations on the Structural Characteristics that Seed the Aggregation of Amyloid-β<sub>1-42</sub> Peptide: Insights from Molecular Dynamics Simulations
Current Proteomics Diagnosis and Treatment of Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Threshold-Independent Meta-Analysis of Alzheimer`s Disease Transcriptomes shows Progressive Changes in Hippocampal Functions, Epigenetics and microRNA Regulation
Current Alzheimer Research Cutting through the Complexities of mTOR for the Treatment of Stroke
Current Neurovascular Research Patient Involvement and Shared Decision-Making in Mental Health Care
Current Clinical Pharmacology Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Intracellular Amyloid β-Protein and Its Associated Molecules in the Pathogenesis of Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Nanotechnology Approaches to Target Endosomal pH: A Promising Strategy for an Efficient Intracellular Drug, Gene and Protein Delivery
Drug Delivery Letters AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer’s Disease
Current Neuropharmacology Biopsychosocial Predictors of Cognitive Impairment in the Elderly: A Case-control Study
Current Psychiatry Research and Reviews Gene and Cell Therapy for Prion Diseases
Infectious Disorders - Drug Targets Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Role of Type 2 Fibroblast Growth Factor in Periodontal Therapy
Current Drug Targets Inflammatory Cardiovascular Risk Markers in Obstructive Sleep Apnoea Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches
Current Neuropharmacology The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology HIV-1 Tat Protein Exposure Potentiates Ethanol Reward and Reinstates Extinguished Ethanol-Conditioned Place Preference
Current HIV Research Current Perspectives on Anti-Aging Interventions
Letters in Drug Design & Discovery Cholinergic System and Neuroinflammation: Implication in Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry